Eris Lifesciences Ltd (ERIS)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1705.00
% Change: 0.06% (Prev Close: 1704.00)

Volume: 91,005
% Change: -15.67% (Prev Volume: 1,07,911)

Delivery: 68,383
Delivery % : 75.14
% Change: -4.36% (Prev Delivery: 71,502)

Turnover: 1,558 Lacs
% Change: -15.87% (Prev Turnover: 1,852)

πŸ’Ή EOD Valuation

P/E Ratio: 59.95
P/B Ratio: 8.13
Market Cap: 23222 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ERIS
Market Cap: 24520 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1910.00
52 Week Low: 1097.20

All-Time High: 1910.00 Rs.
All-Time Low: 321.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-1.56% | 8.64% | 39.55% | 23.23% | 36.55%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 54.83%

Change (3Y | 1Y): 2.53% | -0.02%

Pledged %: 16.93%

FII Holding

FII Holding: 8.39%

Change (3Y | 1Y): -6.96% | -0.04%

DII Holding

DII Holding: 18.18%

Change (3Y | 1Y): 7.52% | 0.11%

Public Holding: 18.59%

🏦 Financial Strength

Debt to Equity: 0.87
Debt: 2477.92 Rs. Cr.

Book Value: 209.63 Rs.
Current Ratio: 0.88
Interest Coverage: 3.44
Free Cash Flow: 910.38 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 30.27%

Sales Growth Qtr (YOY | QoQ):
7.40% | 9.60%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
21.92% | 29.03% | 30.27%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 1.75%

Profit Growth Qtr (YOY | QoQ):
41.63% | 22.23%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.71% | -4.94% | 1.75%

EPS Rs.

EPS (TTM): 28.44 Rs.

EPS Qtr (Last Year | Latest):
6.12 Rs. | 8.66 Rs.

EPS Annual (Last Annual | Annual March):
28.82 Rs. | 25.84 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
3.65% | -4.99%

Net Profit Rs. Cr.

Net Profit (TTM): 410.86 Rs. Cr.

Net Profit (Annual - March): 374.67 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
89.55| 102.35 | 125.10

EBITDA Rs. Cr.

EBITDA (Quarter): 280.29 Rs. Cr.
EBITDA (Previous Yr Ql): 251.63 Rs. Cr.

EBITDA (Annual - March): 1033.54 Rs. Cr.
EBITDA (Previous Annual): 695.26 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
22.26% | 26.28%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 35.42%

OPM Qtr (Previous | Current):
35.78% | 35.80%

OPM Annual (5 Yrs | Last Yr | March):
34.48% | 33.69% | 35.18%

Return on Equity %

ROE: 12.88%

ROE (5 Yrs | 3 Yrs | Last Yr):
18.16% | 15.60% | 16.28%

Return on Capital Employed %

ROCE: 12.22%

ROCE (5 Yrs | 3 Yrs | Last Yr):
18.53% | 13.40% | 11.27%

Return on Assets %

ROA (TTM): 5.54%

ROA (5 Yrs | 3 Yrs | Last Yr):
13.65% | 8.81% | 7.78%

PEG Ratio: -12.82
Dividend Yield: 0.41%

PE 3 Yrs: 31.58
PE 5 Yrs: 27.00

Dividend Yield: 0.41%

πŸ‘₯ Company

Eris Lifesciences Ltd

ERIS

Promoter Holding: %